Abstract
The CB1 receptor is found principally in the central nervous system and is responsible for the overt physiological effects of cannabinoids. In contrast, the CB2 receptor is expressed primarily in the immune system and is responsible for few, if any, obvious behavioral effects. Although many cannabinoid receptor ligands show little, or at best modest, selectivity for either receptor, a number of synthetic compounds are known which have significant selectivity for the CB2 receptor. These include cannabimimetic indoles, such as 1-propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015) and 1-(2,3-dichlorobenzoyl)-2-methyl-3-(2-[1-morpholino] ethyl)-5-methoxyindole (L768242), both of which have good affinity for the CB2 receptor, but weak affinity for the CB1 receptor. Efforts have been made to develop structure-activity relationships (SAR) at CB2 for cannabimimetic indoles, but with limited success. Several derivatives of traditional dibenzopyran based cannabinoids have also been found to have significant selectivity for the CB2 receptor. These include 1- methoxyΔ8-THC derivatives, 1-methoxyΔ8-THC-DMH (L759633), 1-methoxyΔ9(11)-THC-DMH (L759656), and 1-methoxy-3-(1,1-dimethylhexyl)Δ8-THC (JWH-229), plus a number of 1-deoxyΔ8-THC analogues. In particular, 1-deoxy-3-(1,1-dimethylbutyl)Δ8-THC (JWH-133) shows two hundred-fold selectivity for the CB2 receptor. Very recently several compounds belonging to other structural groups have also shown selectivity for the CB2 receptor. This review will describe the current status of the results of these studies and discuss the SAR for these classes of ligands.
Keywords: cannabinoids, deoxy cannabinoids, cb receptor, aminoalkylindoles
Mini-Reviews in Medicinal Chemistry
Title: CB2 Receptor Ligands
Volume: 5 Issue: 7
Author(s): J. W. Huffman
Affiliation:
Keywords: cannabinoids, deoxy cannabinoids, cb receptor, aminoalkylindoles
Abstract: The CB1 receptor is found principally in the central nervous system and is responsible for the overt physiological effects of cannabinoids. In contrast, the CB2 receptor is expressed primarily in the immune system and is responsible for few, if any, obvious behavioral effects. Although many cannabinoid receptor ligands show little, or at best modest, selectivity for either receptor, a number of synthetic compounds are known which have significant selectivity for the CB2 receptor. These include cannabimimetic indoles, such as 1-propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015) and 1-(2,3-dichlorobenzoyl)-2-methyl-3-(2-[1-morpholino] ethyl)-5-methoxyindole (L768242), both of which have good affinity for the CB2 receptor, but weak affinity for the CB1 receptor. Efforts have been made to develop structure-activity relationships (SAR) at CB2 for cannabimimetic indoles, but with limited success. Several derivatives of traditional dibenzopyran based cannabinoids have also been found to have significant selectivity for the CB2 receptor. These include 1- methoxyΔ8-THC derivatives, 1-methoxyΔ8-THC-DMH (L759633), 1-methoxyΔ9(11)-THC-DMH (L759656), and 1-methoxy-3-(1,1-dimethylhexyl)Δ8-THC (JWH-229), plus a number of 1-deoxyΔ8-THC analogues. In particular, 1-deoxy-3-(1,1-dimethylbutyl)Δ8-THC (JWH-133) shows two hundred-fold selectivity for the CB2 receptor. Very recently several compounds belonging to other structural groups have also shown selectivity for the CB2 receptor. This review will describe the current status of the results of these studies and discuss the SAR for these classes of ligands.
Export Options
About this article
Cite this article as:
Huffman W. J., CB2 Receptor Ligands, Mini-Reviews in Medicinal Chemistry 2005; 5 (7) . https://dx.doi.org/10.2174/1389557054368844
DOI https://dx.doi.org/10.2174/1389557054368844 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Insulin and the Brain
Current Diabetes Reviews Vaccination Against High Blood Pressure
Current Pharmaceutical Design RNA Interference-Based Therapeutics: New Strategies to Fight Infectious Disease
Infectious Disorders - Drug Targets Novel Coronavirus 2019 Outbreak: A Global Epidemic
Letters in Drug Design & Discovery Structure-Activity Relationships and Mechanism of Action of Macrolides Derived from Erythromycin as Antibacterial Agents
Current Topics in Medicinal Chemistry Electronic-Topological Study of the Structure-Activity Relationships in a Series of Piperidine Morphinomimetics
Current Medicinal Chemistry The Discovery of Epidepride and Its Analogs as High-Affinity Radioligands for Imaging Extrastriatal Dopamine D2 Receptors in Human Brain
Current Pharmaceutical Design Nanotechnology can Provide Therapeutic Agent by Targeting Molecular Structures of SARS-CoV-2 (COVID-19): A Mini-Review
Letters in Drug Design & Discovery HIV-1 Neutralization: Mechanisms and Relevance to Vaccine Design
Current HIV Research Molecular Modeling of Cytochrome P450 and Drug Metabolism
Current Drug Metabolism Possible Role of PTEN Expression in Discriminating Benign Endometrial Hyperplasia from Atypical Hyperplasia/Endometrial Intraepithelial Neoplasia in a Series of Egyptian Patients
Current Women`s Health Reviews Clinical Approaches to Minimize Readmissions of Patients with COPD: A Narrative Review
Current Respiratory Medicine Reviews Inhibiting Glutathione Metabolism in Lung Lining Fluid as a Strategy to Augment Antioxidant Defense
Current Enzyme Inhibition The Role of Angiotensin-Converting Enzyme in Immunity: Shedding Light on Experimental Findings
Endocrine, Metabolic & Immune Disorders - Drug Targets Induction of Apoptosis by Pierisin-6 in HPV Positive HeLa and HepG2 Cancer Cells is Mediated by the Caspase-3 Dependent Mitochondrial Pathway
Anti-Cancer Agents in Medicinal Chemistry New Targets for Antibacterial Design: Kdo Biosynthesis and LPS Machinery Transport to the Cell Surface
Current Medicinal Chemistry COVID-19-associated Coagulopathy: Role of Vitamins D and K
Current Pharmaceutical Biotechnology Chronic Obstructive Pulmonary Disease and Oxidative Stress
Current Pharmaceutical Biotechnology QSAR of SARS-CoV-2 Main Protease Inhibitors Utilizing Theoretical Molecular Descriptors
Letters in Drug Design & Discovery Recent Advances in N-Heterocycles for COVID-19 Treatment - A Mini Review
Medicinal Chemistry